Search for: "Hoffmann v. Hoffmann"
Results 421 - 440
of 463
Sort by Relevance
|
Sort by Date
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
21 Nov 2008, 11:36 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) – Canada: Supreme Court upholds selection patents: Apotex v Sanofi-Synthelabo Canada et al (Pharmacapsules @ Gowlings)… [read post]
18 Nov 2008, 10:00 am
Snyder v. [read post]
6 Nov 2008, 4:49 pm
Hoffmann-LaRoche, Ltd., 368 U.S. [read post]
6 Nov 2008, 2:43 pm
Nominiert für IP-Recht sind: Hoffmann Eitle Jonas Krieger Mes & Graf v. der Groeben Lovells Taylor Wessing Wir fiebern im Geiste mit und wünschen allen Beteiligten viel Glück! [read post]
28 Oct 2008, 5:52 am
On this basis there was no infringement.* The prior art cited by ACS did not emcompass the invention described in Ancon's patent, so the challenge to its validity failed.The IPKat notes the judge's reliance on, among other decisions, that of the House of Lords in Kirin-Amgen Inc. v Hoechst Marion Roussel Ltd, in which Lord Hoffmann rewrote, clarified or invented the British law on claim construction, depending on how you read the law that came before it. [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US: Pharmaceutical… [read post]
14 Oct 2008, 4:55 am
Noonan -- On October 2, 2008, Judge William Young of the District Court of the District of Massachusetts issued his 150-page opinion in Amgen Inc. v. [read post]
11 Oct 2008, 4:45 am
Hoffmann-La Roche Ltd., Amgen's patent infringement suit over Roche's Mircera ® drug product. [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist' defense… [read post]
10 Oct 2008, 4:28 am
Hoffmann-LaRoche, Amgen's patent infringement suit over Roche's Mircera ® drug product. [read post]
9 Oct 2008, 3:00 am
Mass) issued a decision on post-trial motions and a permanent injunction in Amgen Inc. v. [read post]
7 Oct 2008, 4:50 am
Mass) issued a decision on post-trial motions and a permanent injunction in Amgen Inc. v. [read post]
2 Oct 2008, 12:36 pm
In Eck v. [read post]
25 Sep 2008, 4:22 pm
Hoffmann-La Roche Ltd. v. [read post]
Disclosure of gene from one bacterial source cannot support claims to gene from any bacterial source
22 Sep 2008, 2:46 pm
Hoffmann-La Roche, Inc. after the jump. [read post]
19 Sep 2008, 5:54 am
Highlights include the following morsels: • Generics v Lundbeck, in which Lord Hoffmann sat in the Court of Appeal for England and Wales and gave the leading opinion regarding the concept of Biogen insufficiency in patent law;• Conor v Angiotech, a House of Lords decision concerning taxol-coated coronary stents in which Lord Hoffmann also gave the leading opinion. [read post]
13 Sep 2008, 9:58 pm
Hoffmann-LaRoche:[Roche argued for claims] invalid for lack of written description under our holding in Regents of University of California v. [read post]
10 Sep 2008, 6:54 pm
Hoffmann-La Roche (07-1266). [read post]
10 Sep 2008, 4:55 am
Patent No. 6,017,745 are invalid, and that the remainder of the asserted claims of the '745 patent are not infringed by Defendants-Appellees Hoffmann-La Roche, Inc., Roche Molecular Systems, Inc., Roche Diagnostic Systems, Inc., Roche Biomedical Laboratories, Inc., The Perkin Elmer Corporation, Laboratory Corporation of America Holdings, Roche Diagnostic Corp., Laboratory Corporation of America, and Applera Corp. [read post]
